Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma
Authors:
- Son Dinh An TruongSTSon Dinh An Truong
- Doungdean TummanatsakunDTDoungdean Tummanatsakun
- Tanakorn ProungvitayaTPTanakorn Proungvitaya
- Temduang LimpaiboonTLTemduang Limpaiboon
- Molin WongwattanakulMWMolin Wongwattanakul
- Daraporn Chua-OnDCDaraporn Chua-On
- Sittiruk RoytrakulSRSittiruk Roytrakul
- Siriporn ProungvitayaSPSiriporn Proungvitaya
Open Access
- 8 June 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (6) , 1054
Abstract
The mortality rate of cholangiocarcinoma (CCA) is high since there is a lack of a non-invasive technique to accurately detect tumors at the early stage. CCA biomarkers are consistently needed for various purposes including screening, early diagnosis, prognosis and follow-up. Herein, using bioinformatic analysis of our mitochondrial proteome database of CCA tissues, we identified cytokine-induced apoptosis inhibitor 1 (CIAPIN1) as a potential prognostic biomarker for CCA. CIAPIN1 levels in the sera of 159 CCA patients and 93 healthy controls (HC) were measured using a dot blot assay. The median level ± quartile deviation of CIAPIN1 level in the sera of CCA patient group was 0.5144 ± 0.34 µg/µL, which was significantly higher than 0.2427 ± 0.09 µg/µL of the HC group (p < 0.0001). In CCA patients, higher serum CIAPIN1 level was significantly associated with lymph node metastasis (p = 0.024) and shorter overall survival time (p = 0.001, Kaplan–Meier test). Cox regression analysis showed that the serum CIAPIN1 level can be an independent prognostic indicator for the survival of CCA patients. Moreover, for the prediction of CCA prognosis, CIAPIN1 is superior to CEA, CA19-9 and ALP. In conclusion, CIAPIN1 can be a serum biomarker candidate for the poor prognosis of CCA.Keywords
Funding Information
- AMS grant (xxx)
This publication has 33 references indexed in Scilit:
- Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews Gastroenterology & Hepatology, 2020
- Mitochondrial proteins: from biogenesis to functional networksNature Reviews Molecular Cell Biology, 2019
- CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinomaScientific Reports, 2017
- High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinomaTumor Biology, 2016
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nature Reviews Gastroenterology & Hepatology, 2016
- Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of CholangiocarcinomaAsian Pacific Journal of Cancer Prevention, 2015
- Roles of liver fluke infection as risk factor for cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2014
- Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitisJournal of Hepatology, 2013
- Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis†Hepatology, 2008
- The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing CholangitisDigestive Diseases and Sciences, 2005